Live Breaking News & Updates on Contact Sigyn Therapeutics Inc

Stay updated with breaking news from Contact sigyn therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The Closing Bell Featuring Sigyn Therapeutics


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
The Closing Bell Featuring Sigyn Therapeutics
Sigyn Therapeutics, Inc.April 21, 2021 GMT
The Interactive Videoconference Occurs Today at 4pm Eastern / 1pm Pacific Time
SAN DIEGO, April 21, 2021 (GLOBE NEWSWIRE) via NewMediaWire Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome, announces that its Chairman and CEO, Jim Joyce, will be featured on the Closing Bell videoconference hosted by Force Family Offices at 4pm Eastern today.  This interactive event provides investors with an opportunity to talk directly with Mr. Joyce regarding the advancement of Sigyn Therapy™, a novel blood purification technology designed to treat sepsis and other life-threatening conditions that are induced by cytokine storm syndrome.  Also participating in ....

United States , San Diego , Rob Goldman , Jim Joyce , White Fund , Sigyn Therapeutics Inc , Goldman Small Cap Research , Family Office , Newmediawire Sigyn Therapeutics Inc , Contact Sigyn Therapeutics Inc , Rob Goldman At Small Cap Research , Josephthal Co , Family Offices , Piper Jaffray Technology , Growth Research Group , Interactive Videoconference Occurs Today , Pacific Time , Cytokine Storm Syndrome , Closing Bell , Force Family Offices , Sigyn Therapy , California United , Goldman Small Cap , Piper Jaffray , Washington Based Emerging Growth Research , Chief Investment Officer ,

Sigyn Therapeutics (SIGY) CEO Note: Overcoming the Limitations of Previous Cytokine Storm Treatment Strategies


Sigyn Therapeutics (SIGY) CEO Note: Overcoming the Limitations of Previous Cytokine Storm Treatment Strategies
SAN DIEGO, Jan. 12, 2021 via
NewMediaWire Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce.
Dear Current and Candidate Shareholders,
We created Sigyn Therapy to address a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome (the Cytokine Storm).  An annual market opportunity that exceeds $20 billion.
Based on our cumulative experience in developing first-in-industry medical technologies, we designed Sigyn Therapy to overcome the limitations of previous strategies to treat cytokine storm related conditions, yet still optimize patient safety and support widespread deployment. ....

United States , San Diego , Jim Joyce , Contact Sigyn Therapeutics Inc , Reign Resources Corporation Quarterly Report On Form , Sigyn Therapeutics Inc , Drug Administration , Sigyn Therapeutics , Candidate Shareholders , Sigyn Therapy , Cytokine Storm Syndrome , Cytokine Storm , Investigational Device Exemption , United States Food , Aethlon Medical , Nasdaq Traded Company , California United , Private Securities Litigation Reform Act , Reign Resources Corporation Quarterly Report , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , ஜிம் மகிழ்ச்சி , ஆட்சி வளங்கள் நிறுவனம் காலாண்டு அறிக்கை ஆன் வடிவம் , வேட்பாளர் பங்குதாரர்கள் , ஒன்றுபட்டது மாநிலங்களில் உணவு , நாஸ்டாக் வர்த்தகம் செய்யப்பட்டது நிறுவனம் ,